Byrne Asset Management’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513 | Sell |
225
-25
| -10% | -$57 | ﹤0.01% | 531 |
|
|
2025
Q1 | $388 | Hold |
250
| – | – | ﹤0.01% | 547 |
|
|
2024
Q4 | $588 | Sell |
250
-1,150
| -82% | -$2.71K | ﹤0.01% | 525 |
|
|
2024
Q3 | $5.08K | Sell |
1,400
-100
| -7% | -$363 | ﹤0.01% | 454 |
|
|
2024
Q2 | $5K | Sell |
1,500
-300
| -17% | -$999 | ﹤0.01% | 442 |
|
|
2024
Q1 | $11.5K | Sell |
1,800
-900
| -33% | -$5.74K | 0.01% | 349 |
|
|
2023
Q4 | $17.9K | Buy |
+2,700
| New | +$17.9K | 0.01% | 304 |
|